The single-tablet dual-mechanism therapy initiated in high-risk hypertensive patients significantly reduced the risk of morbidity and mortality by 20% compared with conventional therapy. Heartwire
Current smokers have increased platelet inhibition and lower platelet aggregation while receiving clopidogrel than nonsmokers, a new study has shown. Medscape Medical News
For the first time, the American Society of Clinical Oncology has released several key research findings ahead of its annual meeting, being held later this month. Medscape Medical News
Adding tirofiban to therapy with clopidogrel, aspirin, and heparin while the patient is in transit to a PCI center improves ST-segment resolution; outcomes may also improve, the trial hinted. Heartwire
Review newer right ventricle imaging techniques that might enhance diagnosis of patients with PAH, and assess appropriate evidence-based treatment strategies.
The largest study to date of A1C levels and mortality risk confirms that A1C levels are strongly associated with subsequent mortality in both men and women without a previous diabetes diagnosis. Medscape Medical News
